"Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the New Drug Re-examination."

CompletedOBSERVATIONAL
Enrollment

193

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 10, 2020

Study Completion Date

November 10, 2020

Conditions
Dyslipidemias
Trial Locations (10)

12048

Namyangju Hanyang General Hospital, Gyeonggi-do

14577

Daesung Medical Center, Bucheon-si

35365

Konyang University Hospital, Daejeon

42612

Hyundai Medical Clinic, Daegu

42812

SANGIN Clinic of Internal Medicine, Daegu

47354

Isam Clinic, Busan

47889

DongRae BongSeng Hospital, Busan

53042

Kim Young Ho Internal Medicine Clinic, Gyeongsang

02841

Korea University Anam Hospital, Seoul

06973

Chung-Ang University Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY